Table 1. The results of the OSPL-502 concentration determination in plasma samples taken at appropriate time intervals, with oral (i/p) and intravenous administration (i/v) of the dosage form (mg/kg) in terms of the substance.
| Time, h | Concentration of OSPL-502, ng/ml | |
| 10, i/p | 2, i/v | |
| 0,25 | 1992,43 ± 607.54 | 2740,22 ± 694,15 | 
| 0,5 | 1229,68 ± 18,78 | 185,65 ± 40,29 | 
| 0,75 | 1388,14 ± 74,27 | 161,16 ± 35,94 | 
| 1 | 822,21 ± 53,82 | 132,43 ± 20,33 | 
| 1,5 | 2451,71 ± 256,32 | 103,24 ± 26,12 | 
| 2 | 1741,54 ± 247,44 | 33,34 ± 17,85 | 
| 4 | 726, 22 ± 117,72 | 7,24 ± 3,14 | 
| 8 | 676,77 ± 145,23 | 4,22 ± 2,31 | 
| 16 | 377,89 ± 7,87 | --- | 
| 24 | 312,24 ± 25,34 | --- |